Aspirin sensitizes osimertinib‐resistant NSCLC cells <i>in vitro</i> and <i>in vivo</i> via Bim‐dependent apoptosis inductionRui Han(Army Medical University)Molecular OncologyApril 2, 202010.1002/1878-0261.12682Cited by 31SaveCiteExport RISWatch citationsRelated PapersBrigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer|Acta Pharmacologica Sinica|2024|20